Helix BioPharma Corp. Common

(HBP:CA)

By |

Profile

Helix BioPharma Corp is a Canada-based clinical-stage biopharmaceutical company focused on cancer drug development. It develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. The company has Tumor Defense Breakers (L-DOS47), and Tumor Attackers (CAR-T) product candidates in the pipeline.

Contact Information

Website: www.helixbiopharma.com
Email: helix@helixbiopharma.com
Main Phone: +1 905 841-2300
Address: 9120 Leslie Street
Address 2: Suite 205
State: ON
City / Town: Richmond Hill
Country: CA
Postal Code: L4B 3J9

Issuer Information

Exchange: TSX
CEO: Heman Chao
Employees: 19
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Helix BioPharma Corp is a Canada-based clinical-stage biopharmaceutical company focused on cancer drug development. It develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. The company has Tumor Defense Breakers (L-DOS47), and Tumor Attackers (CAR-T) product candidates in the pipeline.

Contact Information

Website: www.helixbiopharma.com
Email: helix@helixbiopharma.com
Main Phone: +1 905 841-2300
Address: 9120 Leslie Street
Address 2: Suite 205
State: ON
City / Town: Richmond Hill
Country: CA
Postal Code: L4B 3J9

Issuer Information

Exchange: TSX
CEO: Heman Chao
Employees: 19
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.44 $ 0.005 (1.16%)
Last Price 0.44 Change $ 0.005 Change % 1.16 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.44 High 0.44 Low 0.44 Prev Close 0.43
Last Trade Volume 1,715 52 Wk Hi 2.01 52 Wk Low 0.42
Market Cap 57.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 132,933,017.00 EPS (TTM) -0.07 PE Ratio N/A Exchange TSX
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1